{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:00:58Z","timestamp":1790096458845,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00284-026-05024-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:24:00Z","timestamp":1785173040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vivo Activity of Combination of N-acetyl Cysteine and Levofloxacin against Colonization and Catheter-Associated Infection"],"prefix":"10.1007","volume":"83","author":[{"given":"M. David","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena L.","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"5024_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11908-001-0086-4","volume":"3","author":"CJ Crnich","year":"2001","unstructured":"Crnich CJ, Maki DG (2001) The role of intravascular devices in sepsis. Curr Infect Dis Rep 3:496\u2013506","journal-title":"Curr Infect Dis Rep"},{"key":"5024_CR2","unstructured":"O\u2019Grady NP, Alexander M, Burns LA et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention (CDC)"},{"key":"5024_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMra011883","volume":"348","author":"DC McGee","year":"2003","unstructured":"McGee DC, Gould MK (2003) Preventing complications of central venous catheterization. N Engl J Med 348:1123\u20131133","journal-title":"N Engl J Med"},{"issue":"137","key":"5024_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01180-1","volume":"11","author":"V Pitiriga","year":"2022","unstructured":"Pitiriga V, Bakalis J, Theodoridou K et al (2022) Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients. Antimicrob Resist Infect Control 11(137):1\u20137","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"5024_CR5","first-page":"432","volume":"4","author":"FO Odetola","year":"2003","unstructured":"Odetola FO, Moler FW, Dechert RE et al (2003) Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies Pediatr. Crit Care Med 4(4):432\u2013436","journal-title":"Crit Care Med"},{"key":"5024_CR6","unstructured":"Chopra V, Felix K, Johns K (2020) Central Line-Associated Bloodstream Infection (CLABSI): an introduction. Centers for Disease Control and Prevention (CDC) https:\/\/www.cdc.gov\/infectioncontrol\/pdf\/strive\/CLABSI101-508.pdf"},{"key":"5024_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1086\/604719","volume":"49","author":"J Brown","year":"2009","unstructured":"Brown J, Doloresco F III, Mylotte JM (2009) Never events: not every hospital acquired-infection is preventable. Clin Infect Dis 49:743\u2013746","journal-title":"Clin Infect Dis"},{"key":"5024_CR8","doi-asserted-by":"crossref","unstructured":"McNair PD, Luft HS, Bindman AB (2009) Medicare\u2019s policy not to pay for treating hospital-acquired conditions: the impact. Health Aff (Millwood) (5):1485\u20131493","DOI":"10.1377\/hlthaff.28.5.1485"},{"key":"5024_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1074-5521(02)00192-8","volume":"9","author":"PN Danese","year":"2002","unstructured":"Danese PN (2002) Antibiofilm approaches: prevention of catheter colonization. Chem Biol 9:873\u2013880","journal-title":"Chem Biol"},{"key":"5024_CR10","doi-asserted-by":"crossref","unstructured":"Hockenhull JC, Dwan K, Boland A et al (2008) The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol. Assess. 12:iii-iv, xi-xii, 1-154","DOI":"10.3310\/hta12120"},{"issue":"Suppl 2","key":"5024_CR11","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1089\/sur.2006.7.s2-25","volume":"7","author":"G Donelli","year":"2006","unstructured":"Donelli G (2006) Vascular catheter-related infection and sepsis. Surg Infect (Larchmt) 7(Suppl 2):S25\u2013S27","journal-title":"Surg Infect (Larchmt)"},{"key":"5024_CR12","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1128\/AAC.01622-05","volume":"50","author":"H Hanna","year":"2006","unstructured":"Hanna H, Bahna P, Reitzel R et al (2006) Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother 50:3283\u20133288","journal-title":"Antimicrob Agents Chemother"},{"key":"5024_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/01.CCM.0000201404.05523.34","volume":"34","author":"D Fraenkel","year":"2006","unstructured":"Fraenkel D, Rickard C, Thomas P et al (2006) A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum carbon-impregnated central venous catheters. Crit Care Med 34:668\u2013675","journal-title":"Crit Care Med"},{"key":"5024_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/039139880502801103","volume":"28","author":"JW Costerton","year":"2005","unstructured":"Costerton JW, Montanaro L, Arciola CR (2005) Biofilm in implant infections: its production and regulation. Int J Artif Organs 28:1062\u20131068","journal-title":"Int J Artif Organs"},{"key":"5024_CR15","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1128\/AEM.71.5.2705-2712.2005","volume":"71","author":"AC Olofsson","year":"2005","unstructured":"Olofsson AC, Hermansson M, Elwing H (2005) Use of a quartz crystal microbalance to investigate the antiadhesive potential of N-acetyl-Lcysteine. Appl Environ Microbiol 71:2705\u20132712","journal-title":"Appl Environ Microbiol"},{"key":"5024_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1128\/AAC.05836-11","volume":"56","author":"I Raad","year":"2012","unstructured":"Raad I, Mohamed JA, Reitzel RA et al (2012) Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56:935\u2013941","journal-title":"Antimicrob Agents Chemother"},{"key":"5024_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1586\/14787210.4.1.9","volume":"4","author":"GG Zhanel","year":"2006","unstructured":"Zhanel GG, Karlowsky JA, Rubinstein E et al (2006) Tigecycline: a novel glycylcycline antibiotic. Expert Rev Anti Infect Ther 4:9\u201325","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5024_CR18","doi-asserted-by":"crossref","unstructured":"Siegrist HH, Nepa MC, Jacquet A (1999) Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology\/oncology patients in Switzerland: a multicentre study. J Antimicrob Chemother 43 Suppl C :51\u201354","DOI":"10.1093\/jac\/43.suppl_3.51"},{"key":"5024_CR19","first-page":"184","volume":"18","author":"G Agarwal","year":"2005","unstructured":"Agarwal G, Kapil A, Kabra SK et al (2005) In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms. Natl Med J India 18:184\u2013186","journal-title":"Natl Med J India"},{"key":"5024_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/infdis\/170.3.720","volume":"170","author":"RO Darouiche","year":"1994","unstructured":"Darouiche RO, Dhir A, Miller AJ et al (1994) Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 170:720\u2013723","journal-title":"J Infect Dis"},{"key":"5024_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0196-0644(05)81352-6","volume":"20","author":"MJ Smilkstein","year":"1991","unstructured":"Smilkstein MJ, Bronstein AC, Linden C et al (1991) Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 20:1058\u20131063","journal-title":"Ann Emerg Med"},{"key":"5024_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00228-004-0850-0","volume":"60","author":"D Soldini","year":"2005","unstructured":"Soldini D, Zwahlen H, Gabutti L et al (2005) Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients. Eur J Clin Pharmacol 60:859\u2013864","journal-title":"Eur J Clin Pharmacol"},{"key":"5024_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11882-005-0044-6","volume":"5","author":"A Yuta","year":"2005","unstructured":"Yuta A, Baraniuk JN (2005) Therapeutic approaches to mucus hypersecretion. Curr Allergy Asthma Rep 5:243\u2013251","journal-title":"Curr Allergy Asthma Rep"},{"key":"5024_CR24","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1128\/AEM.69.8.4814-4822.2003","volume":"69","author":"AC Olofsson","year":"2003","unstructured":"Olofsson AC, Hermansson M, Elwing H (2003) N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol 69:4814\u20134822","journal-title":"Appl Environ Microbiol"},{"key":"5024_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioflm.2025.100296","volume":"10","author":"A Manoharan","year":"2025","unstructured":"Manoharan A, Whiteley G, Kuppusamy R et al (2025) Combating biofilm formation and bacterial killing: N-acetylcysteine\u2019s efficacy against Pseudomonas aeruginosa in urinary catheters. Biofilm 10:1\u201311","journal-title":"Biofilm"},{"key":"5024_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/AAC.01646-12","volume":"57","author":"MD Mansouri","year":"2013","unstructured":"Mansouri MD, Hull R, Stager C et al (2013) In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization. Antimicrob Agents Chemother 57:621\u2013625","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5024_CR27","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1111\/jam.15490","volume":"132","author":"MD Mansouri","year":"2022","unstructured":"Mansouri MD, Ramanathan V, Mansouri DL et al (2022) In vitro activities of N-acetyl cysteine and levofloxacin as a catheter lock therapy against catheter-associated infections. J Appl Microbiol 132(5):3915\u20133924","journal-title":"J Appl Microbiol"},{"key":"5024_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1086\/650757","volume":"31","author":"T Matheos","year":"2010","unstructured":"Matheos T, Walz JM, Adams JP et al (2010) Comparison of the duration of antimicrobial activity of 2 different antimicrobial central venous catheters. Infect Control Hosp Epidemiol 31:295\u2013297","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5024_CR29","doi-asserted-by":"publisher","first-page":"1435125","DOI":"10.3389\/fcell.2024.1435125","volume":"12","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Sun L et al (2024) The role of N-acetylcysteine in osteogenic microenvironment for bone tissue engineering. Front Cell Dev Biol 12:1435125","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"5024_CR30","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1021\/jm9909600","volume":"43","author":"B Nosz\u00e1l","year":"2000","unstructured":"Nosz\u00e1l B, Visky D, Kraszni M (2000) Population, acid-base, and redox properties of N-acetylcysteine conformers. J Med Chem 43(11):2176\u20132182","journal-title":"J Med Chem"},{"issue":"4","key":"5024_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijantimicag.2006.11.018","volume":"29","author":"MD Mansouri","year":"2007","unstructured":"Mansouri MD, Darouiche RO (2007) In vitro antimicrobial activity of N-acetyl cysteine against bacterial colonized central venous catheters. Int J Antimicrob Agents 29(4):474\u2013476","journal-title":"Int J Antimicrob Agents"},{"key":"5024_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1128\/AAC.45.5.1535-1538.2001","volume":"45","author":"S Bassetti","year":"2001","unstructured":"Bassetti S, Hu J, D\u2019Agostino RB Jr et al (2001) Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 45:1535\u20131538","journal-title":"Antimicrob Agents Chemother"},{"key":"5024_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1469-0691.2007.01894.x","volume":"14","author":"MD Mansouri","year":"2008","unstructured":"Mansouri MD, Darouiche RO (2008) In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens. Clin Microbiol Infect 14:190\u2013192","journal-title":"Clin Microbiol Infect"},{"key":"5024_CR34","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1128\/AAC.05521-11","volume":"56","author":"MD Mansouri","year":"2012","unstructured":"Mansouri MD, Opperman TJ, Williams JD et al (2012) In vitro potency and in vivo efficacy of a novel bis-indole antimicrobial compound in reducing catheter colonization. Antimicrob Agents Chemother 56:2201\u20132204","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5024_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhin.2010.07.009","volume":"76","author":"MD Mansouri","year":"2010","unstructured":"Mansouri MD, Ramanathan V, Al-Sharif AH et al (2010) Efficacy of trypsin in enhancing assessment of bacterial colonisation of vascular catheters. J Hosp Infect 76(4):328\u2013331","journal-title":"J Hosp Infect"},{"issue":"1","key":"5024_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/AAC.01646-12","volume":"57","author":"MD Mansouri","year":"2013","unstructured":"Mansouri MD, Hull RA, Stager CE et al (2013) In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization. Antimicrob Agents Chemother 57(1):621\u2013625","journal-title":"Antimicrob Agents Chemother"},{"key":"5024_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1088\/0031-9155\/34\/2\/002","volume":"34","author":"M Cervera","year":"1989","unstructured":"Cervera M, Dolz M, Herraez JV et al (1989) Evaluation of the elastic behaviour of central venous PVC, polyurethane and silicone catheters. Phys Med Biol 34:177\u2013183","journal-title":"Phys Med Biol"},{"key":"5024_CR38","first-page":"1","volume":"1","author":"International Organization for Standardization","year":"2009","unstructured":"International Organization for Standardization (2009) ISO, EN ISO 10555-1; sterile, single-use intravascular catheters, part 1: general requirements (ISO 10555-1: 1995, including Amd 1:1999 and Amd 2:2004). Br Standard\/European Standard 1:1\u20139","journal-title":"Br Standard\/European Standard"},{"issue":"3","key":"5024_CR39","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/0300060517708944","volume":"45","author":"YJ Choi","year":"2017","unstructured":"Choi YJ, Lim JK, Park JJ et al (2017) Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation. J Int Med Res 45(3):1042\u20131053","journal-title":"J Int Med Res"},{"key":"5024_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/sur.2006.073","volume":"208","author":"DJ Schuerer","year":"2007","unstructured":"Schuerer DJ, Zack JE, Thomas J et al (2007) Effect of chlorhexidine\/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. Surg Infect (Larchmt) 208:445\u2013454","journal-title":"Surg Infect (Larchmt)"},{"key":"5024_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhin.2009.03.018","volume":"72","author":"LF Camargo","year":"2009","unstructured":"Camargo LF, Marra AR, B\u00fcchele GL et al (2009) Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. J Hosp Infect 72:227\u2013233","journal-title":"J Hosp Infect"},{"issue":"7","key":"5024_CR42","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/jac\/dkaa093","volume":"75","author":"A Manoharan","year":"2020","unstructured":"Manoharan A, Das T, Whiteley GS et al (2020) The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus. J Antimicrob Chemother 75(7):1787\u20131798","journal-title":"J Antimicrob Chemother"},{"key":"5024_CR43","first-page":"10140","volume":"12","author":"T Zhao","year":"2010","unstructured":"Zhao T, Liu Y (2010) N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol 12:10140","journal-title":"BMC Microbiol"},{"issue":"1","key":"5024_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.joen.2011.10.004","volume":"38","author":"SY Quah","year":"2012","unstructured":"Quah SY, Wu S, Lui JN et al (2012) N-acetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis. J Endod 38(1):81\u201385","journal-title":"J Endod"},{"key":"5024_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajic.2007.02.012","volume":"36","author":"P Ramritu","year":"2008","unstructured":"Ramritu P, Halton K, Collignon P et al (2008) A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 36:104\u2013117","journal-title":"Am J Infect Control"},{"key":"5024_CR46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.7326\/0003-4819-143-8-200510180-00007","volume":"143","author":"ME Rupp","year":"2005","unstructured":"Rupp ME, Lisco SJ, Lipsett PA et al (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143:570\u2013580","journal-title":"Ann Intern Med"},{"key":"5024_CR47","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/00000542-199811000-00060","volume":"89","author":"E Terazawa","year":"1998","unstructured":"Terazawa E, Shimonaka H, Nagase K et al (1998) Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter. Anesthesiology 89:1296\u20131298","journal-title":"Anesthesiology"},{"key":"5024_CR48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/00000542-199711000-00031","volume":"87","author":"T Oda","year":"1997","unstructured":"Oda T, Hamasaki J, Kanda N et al (1997) Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter. Anesthesiology 87:1242\u20131244","journal-title":"Anesthesiology"},{"key":"5024_CR49","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.hlc.2010.10.001","volume":"20","author":"A Khoo","year":"2011","unstructured":"Khoo A, Oziemski P (2011) Chlorhexidine impregnated central venous catheter inducing an anaphylatic shock in the intensive care unit. Heart Lung Circ 20:669\u2013670","journal-title":"Heart Lung Circ"},{"key":"5024_CR50","first-page":"191","volume":"63","author":"M Faber","year":"2012","unstructured":"Faber M, Leysen J, Bridts C et al (2012) Allergy to chlorhexidine: beware of the central venous catheter. Acta Anaesthesiol Belg 63:191\u2013194","journal-title":"Acta Anaesthesiol Belg"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05024-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:03:49Z","timestamp":1790093029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-05024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5024"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05024-8","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The contents of this manuscript do not represent the views of VA or the United States Government. Dr. David Mansouri and Dr. Rabih Darouiche are the inventors of different patents that describe antimicrobial treatment of medical devices. However, these patents are assigned to Baylor College of Medicine, Houston, TX, and currently, there are no licensing activities associated with these patents.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"491"}}